Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Málaga
Clinical trial register · Spain

Clinical Trials in Málaga, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Madrid 64 Barcelona 57 Valencia 31 Seville 30 Málaga 26
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca66 Janssen Research & Development, LLC30 Merck Sharp & Dohme LLC29 Hoffmann-La Roche28 Bristol-Myers Squibb26 Clear sponsor filter
Site location
Madrid64 Barcelona57 Valencia31 Seville30 Málaga26
All 64 locations
Target enrolment
to

Trials with a site in Málaga

26 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Santander, Santiago de Compostela, Barcelona, Coslada, Girona, Madrid, Málaga, Oviedo
2026-12-16
Recruiting
Bristol-Myers Squibb
Phase 2
160
Badalona, Seville, Barcelona, Madrid, Majadahonda, Málaga
2026-09-10
Recruiting
Bristol-Myers Squibb
Phase 3
850
Majadahonda, Seville, A Coruña, Jaén, Jerez de la Frontera, Madrid, Málaga, Valencia
2026-09-08
Recruiting
Bristol-Myers Squibb
Phase 3
850
L'Hospitalet Del Llobregat, Barcelona, Madrid, Valencia, Barakaldo, Málaga, Seville, Zaragoza
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 2/3
690
Barcelona, Santander, Pamplona, Valencia, Madrid, Málaga
2026-03-13
Recruiting
Bristol-Myers Squibb
Phase 3
750
Barcelona, Barakaldo, Jaén, Madrid, Málaga, Murcia
2026-03-12
Recruiting
Bristol-Myers Squibb
Phase 2/3
590
Barcelona, Hospitalet, Madrid, Majadahonda, Málaga, Seville, Valencia
2026-01-02
Recruiting
Bristol-Myers Squibb
Phase 2/3
990
Santiago de Compostela, Barcelona, Madrid, Pamplona, Badalona, Elche (alicante), Málaga, Salamanca
2025-12-31
Recruiting
Bristol-Myers Squibb
Phase 3
650
Getxo, Elche (alicante), Madrid, Málaga, Pamplona, Salamanca, Seville, Terrassa
2025-12-02
Recruiting
Bristol-Myers Squibb
Phase 2/3
500
Barcelona, Madrid, Majadahonda, Málaga, Seville, Valencia, Zaragoza
2025-11-05
Recruiting
Bristol-Myers Squibb
Phase 1/2
540
Málaga, Badalona, Barcelona, Pamplona, Madrid
2025-10-15
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Badalona, Barcelona, Las Palmas de Gran Canaria, Alcorcón, Málaga, Salamanca, Seville, Madrid
2025-09-22
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
A Coruña, Elche, Barcelona, Hospitalet, Donostia / San Sebastian, Madrid, Málaga, Valencia
2025-09-11
Recruiting
Bristol-Myers Squibb
Phase 2
182
Barcelona, Hospitalet, Madrid, Málaga, Seville, Valencia
2025-09-09
Recruiting
Bristol-Myers Squibb
Phase 3
426
Getxo, Elche (alicante), Madrid, Málaga, Pamplona, Salamanca, Seville, Terrassa
2025-07-10
Recruiting
Bristol-Myers Squibb
Phase 1/2
416
Santiago de Compostela, Barcelona, Hospitalet, Madrid, Majadahonda, Valencia, Málaga, Seville
2025-02-04
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
A Coruña, Barcelona, L'Hospitalet de Llobregat, Palma, Madrid, Majadahonda, Valencia, Málaga
2024-10-07
Recruiting
Bristol-Myers Squibb
Phase 1/2
460
Málaga, Barcelona, Madrid, Pamplona, Salamanca
2023-12-29
Active, closed
Bristol-Myers Squibb
Phase 3
190
A Coruña, Santiago de Compostela, Barcelona, Madrid, Majadahonda, Málaga, Seville, Valencia
2023-12-21
Active, closed
Bristol-Myers Squibb
Phase 2
227
L'Hospitalet de Llobregat, Majadahonda, El Palmar, Madrid, Málaga, Seville, Valencia
2023-11-07
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Badalona, Barcelona, Santander, Santiago de Compostela, Málaga, Madrid, Majadahonda, Oviedo
2023-10-25
Active, closed
Bristol-Myers Squibb
Phase 1/2
100
Málaga, Badalona, Pamplona, Madrid
2023-06-06
Recruiting
Bristol-Myers Squibb
Observational
1,700
Palma de Mallorca, Majadahonda, El Palmar, Oviedo, Burgos, Madrid, Málaga
2022-08-16
Recruiting
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
NCT04895709Cervical Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Microsatellite Stable Colorectal Cancer, Non-Small-Cell Lung Cancer
DrugsImzokitug·Pumitamig·Docetaxel·Nivolumab
Bristol-Myers Squibb
Phase 1/2
1,109
Málaga, Badalona, Barcelona, Madrid, Pamplona
2021-05-27
Active, closed
Bristol-Myers Squibb
Phase 3
790
Barcelona, A Coruña, Badalona, Madrid, Málaga, Santander, Valencia
2019-10-28
Active, closed
Bristol-Myers Squibb
Phase 3
839
Badalona, A Coruña, Barcelona, Madrid, Málaga, Seville, Valencia
2019-08-05
Rows per page Showing 1–26 of 26
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/m-laga

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 26 of those studies with a site in Málaga that also match the filters currently applied.

How many clinical trials are recruiting in Málaga?

19 of the 26 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Málaga), 26 studies
PhaseStudiesRecruitingShare
Phase 312746.2%
Phase 1/25419.2%
Phase 2/35519.2%
Phase 23211.5%
Observational113.8%

Most active sponsors

Lead sponsors with the most studies (Málaga)
Lead sponsorStudiesRecruiting
Bristol-Myers Squibb2619
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.